<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Traction alopecia</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Traction alopecia</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Traction alopecia</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nonhlanhla P Khumalo, MBChB, FCDerm, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paradi Mirmirani, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Maria Hordinsky, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew F Alexis, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Abena O Ofori, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 02, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H203854741"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Traction alopecia is a form of hair loss that results from prolonged or repetitive tension on hair. Traction alopecia most commonly occurs along the frontal or temporal scalp, but can also occur in other sites of the scalp and in other hair-bearing areas  (<a class="graphic graphic_picture graphicRef101621 graphicRef101622 graphicRef101625" href="/z/d/graphic/101621.html" rel="external">picture 1A-C</a>).</p><p>Having a high clinical suspicion for traction alopecia in at-risk populations and obtaining a detailed history of current and past hair care practices is essential for making the diagnosis. Early recognition and cessation of the offending hair care practice is critical because sustained traction can lead to permanent hair loss.</p><p>The clinical features, diagnosis, and management of traction alopecia will be reviewed here. An overview of the evaluation of patients with hair loss is provided separately. (See  <a class="medical medical_review" href="/z/d/html/15678.html" rel="external">"Evaluation and diagnosis of hair loss"</a>.)</p><p class="headingAnchor" id="H203854747"><span class="h1">EPIDEMIOLOGY AND RISK FACTORS</span><span class="headingEndMark"> — </span>Traction alopecia can occur when hair follicles are subjected to prolonged or repetitive tension. Although epidemiologic data on traction alopecia are limited [<a href="#rid1">1-4</a>], it appears that traction alopecia is most frequently diagnosed in females of African descent with Afro-textured hair. The relatively high prevalence in this population is most likely related to the frequent use of traction hairstyles (eg, braids or hair weaves). In support of this theory, traction alopecia occurs in other populations in association with the use of traction hairstyles, such as tight ponytails [<a href="#rid5">5-7</a>], chignon or bun hairstyles (as often worn by ballerinas) [<a href="#rid8">8,9</a>], hair extensions [<a href="#rid10">10</a>], hair pins (as for securing nursing caps) [<a href="#rid11">11</a>], the Sikh practices of tightly twisting long hair on the scalp and knotting the beard hair [<a href="#rid12">12,13</a>], and in females serving in the military who have to adhere to hairstyle regulations [<a href="#rid14">14,15</a>].</p><p>Differences in exposure to traction hairstyles likely contributes to the higher prevalence of traction alopecia in females compared with males and adults compared with children in populations of African descent. In a study of 874 adults in South Africa, traction alopecia was detected in 32 percent of women compared with only 2 percent of men [<a href="#rid1">1</a>]. Increasing prevalence with age was demonstrated in a study of 1042 schoolchildren (ages 6 to 21 years) in South Africa; traction alopecia was present in 9 percent in girls in their first year of school (age 6 to 7 years) compared with 22 percent in girls in their last year of high school (age 17 to 21 years) [<a href="#rid2">2</a>]. No male schoolchildren had traction alopecia. Traction alopecia can also occur in infants. A case report documents traction folliculitis (an early presentation of traction alopecia) in an eight-month-old child [<a href="#rid16">16</a>].</p><p>Limited data suggest that use of chemical relaxers may increase risk for traction alopecia. In a study of 574 South African schoolgirls and 604 South African adult women, girls or women with a history of traction applied to chemically relaxed hair had the highest likelihood for traction alopecia (odds ratio 3.47, CI 1.94-6.20) [<a href="#rid17">17</a>]. A history of certain hair dressing-associated symptoms (pain, pimples, crusts) may also be associated with increased risk for traction alopecia. The same study found that the majority of patients (81 percent) with traction alopecia admitted to a history of tight painful braids, painful pimples, and stinging sensations during chemical relaxers with or without formation of crusts [<a href="#rid17">17</a>].</p><p class="headingAnchor" id="H203854753"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The exact pathogenesis of traction alopecia is yet to be elucidated. Traction on hair may induce a perifollicular inflammatory process that is asymptomatic or associated with clinical signs of folliculitis. As a result of this inflammation, follicles may become miniaturized or dormant, resulting in finer hairs, vellus-like hairs, and reduced hair density [<a href="#rid6">6,18,19</a>].</p><p>Initially, hair loss secondary to traction alopecia is nonscarring and reversible if the cause of traction and the inflammatory reaction is discontinued. With persistent traction, irreversible damage to the hair follicles leads to permanent (scarring) alopecia.</p><p>Further study is necessary to clarify whether the high levels of interleukin (IL) 1-alpha (a proinflammatory cytokine) in scalp sebum relative to levels of IL-1 receptor antagonist (a competitive inhibitor of IL-1-alpha) in scalp sebum detected in a study of 36 asymptomatic Black South African women indicates a proinflammatory state that may predispose women with Afro-textured hair to scalp inflammation and alopecia [<a href="#rid20">20</a>]. Pending further data, exposure to traction hairstyles is considered the primary factor contributing to the development of traction alopecia.</p><p class="headingAnchor" id="H636519"><span class="h1">CLINICAL FEATURES</span><span class="headingEndMark"> — </span>The clinical findings of traction alopecia can include inflammatory papules, pustules, reduced hair density, reduced hair length and caliber, and alopecic patches  (<a class="graphic graphic_table graphicRef102269" href="/z/d/graphic/102269.html" rel="external">table 1</a>). The manifestations depend on the stage and severity of disease. The scalp is the most common site of traction alopecia, with the frontal hairline and the temporal scalp above the ears most frequently affected. However, traction alopecia may appear in other sites on the scalp or in other body areas in which hair follicles are subjected to traction.</p><p>In the earliest stages of traction alopecia, hair loss may be absent or limited to a subtle decrease in hair density. At this stage, patients may have only traction folliculitis, manifesting as perifollicular erythema, perifollicular inflamed papules, or perifollicular sterile pustules in sites of traction  (<a class="graphic graphic_picture graphicRef101620" href="/z/d/graphic/101620.html" rel="external">picture 2</a>) [<a href="#rid16">16</a>]. Patients may describe this presentation as "pimples on the scalp." Scalp scaling and pruritus may accompany traction folliculitis.</p><p>Traction folliculitis can be transient, resolving as tension on the hair follicles decreases due to the removal of traction or hair growth. Therefore, direct questioning may be necessary to determine whether a patient has experienced traction folliculitis.</p><p>With persistent traction, noticeable hair loss occurs, which may progress from decreased hair density to patches of complete alopecia. Marginal traction alopecia, the most common presentation, affects the frontal and temporal scalp above the ears  (<a class="graphic graphic_picture graphicRef101621" href="/z/d/graphic/101621.html" rel="external">picture 1A</a>). However, hair loss in the back of the scalp or occiput can also be seen. The "fringe sign," which is defined as fine or miniaturized residual hairs retained at the margin of the anterior hairline with hair loss posterior to the fringe, typically is present  (<a class="graphic graphic_picture graphicRef101622" href="/z/d/graphic/101622.html" rel="external">picture 1B</a>) [<a href="#rid6">6</a>]. Marginal alopecia often occurs in association with hairstyles incorporating tight ponytails, buns, or braids [<a href="#rid5">5,6</a>].</p><p>Nonmarginal alopecia occurs in areas other than the frontal or temporal scalp. For example, women who frequently wear their hair in a tight chignon or bun can develop patchy hair loss of the occipital scalp. Nonmarginal traction alopecia can also occur as a result of hair extensions [<a href="#rid10">10</a>], pins used to secure hats [<a href="#rid11">11</a>], or other regular use of hair accessories  (<a class="graphic graphic_picture graphicRef101624" href="/z/d/graphic/101624.html" rel="external">picture 3</a>) [<a href="#rid10">10</a>]. Linear, curved, or horseshoe patterns of hair loss can occur when hair is tightly braided on the scalp in preparation for the attachment of sewn-in or glued-in curtain-like hair extensions (hair wefts), as is often done for hair weaves  (<a class="graphic graphic_picture graphicRef101625" href="/z/d/graphic/101625.html" rel="external">picture 1C</a>) [<a href="#rid16">16,21,22</a>].</p><p>The presence of hair casts can be a sign of ongoing traction alopecia [<a href="#rid23">23-26</a>]. Hair casts are moveable collections of white scale that encircle the hair  (<a class="graphic graphic_picture graphicRef101623" href="/z/d/graphic/101623.html" rel="external">picture 4</a>). Hair casts are composed of keratin derived from root sheath cells and occur in association with a variety of scalp disorders [<a href="#rid25">25</a>].</p><p class="headingAnchor" id="H636773"><span class="h1">HISTOPATHOLOGY</span><span class="headingEndMark"> — </span>The histopathologic findings in traction alopecia may differ based upon the stage of disease:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Early traction alopecia </strong>–<strong> </strong>Biopsies of traction alopecia less than one year in duration may demonstrate trichomalacia (twisted or deformed anagen bulbs), increased numbers of telogen and catagen hairs, a normal number of terminal follicles, and preserved sebaceous glands [<a href="#rid6">6</a>]. The dermis may exhibit mild perifollicular chronic inflammation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Late-stage traction alopecia </strong>– Long-standing traction alopecia characteristically demonstrates follicular miniaturization, follicular "drop-out" (loss of terminal hair follicles), and retained sebaceous glands  (<a class="graphic graphic_picture graphicRef101626" href="/z/d/graphic/101626.html" rel="external">picture 5</a>) [<a href="#rid6">6,18,19,27</a>]. Lost terminal follicles are replaced with fibrous tracts. Dermal inflammation is minimal or absent.</p><p></p><p>Although fibrosis is considered a histopathologic feature of late-stage traction alopecia, histopathologic assessment for fibrosis may not be a reliable indicator of the stage of traction alopecia (early versus late-stage) and, additionally, may not correlate with the overall severity of hair loss. A study of specimens from 45 patients with traction alopecia found poor agreement among three dermatopathologists in the assessment for perifollicular and interfollicular fibrosis and did not find a correlation between fibrosis and the clinical severity score [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H203854783"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of traction alopecia usually can be made based upon the clinical evaluation. A history of traction hairstyles with hair loss in a concordant distribution is essential for diagnosis. A history of signs of traction folliculitis (perifollicular erythema, inflamed papules, or pustules at sites of traction) prior to significant hair loss offers additional support for the diagnosis. (See <a class="local">'Clinical features'</a> above.)</p><p>A variety of other scalp and hair disorders can result in patterned hair loss that may be mistaken for traction alopecia. When the diagnosis is uncertain, a skin biopsy can be performed to aid in ruling out other disorders as the cause of hair loss and confirming the diagnosis. The histopathologic findings of traction alopecia are not pathognomonic; therefore, the biopsy must be interpreted in the context of the clinical findings. (See <a class="local">'Histopathology'</a> above.)</p><p class="headingAnchor" id="H178861463"><span class="h2">History</span><span class="headingEndMark"> — </span>A high index of suspicion is often necessary to diagnose traction alopecia, particularly since patients may not associate hair loss with their hairstyling practices. Questions that can be helpful in the evaluation include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>"When did the hair loss start?" and "Was the hair loss sudden in onset or gradual?" </strong>– Hair loss in traction alopecia typically is gradual. Occasionally, hair loss is perceived as acute if associated with another cause of hair shedding (eg, telogen effluvium) or is noted upon removal of braids or weaves [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>"Where have you noticed the most hair loss?" </strong>– Localized or patchy hair loss is characteristic of traction alopecia. Diffuse hair loss or a complaint of hair loss "all over" is not typical of traction alopecia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>"Have you had symptoms in the area of hair loss?"</strong> – If asked specifically, many patients with traction alopecia will admit to symptoms including tenderness, pimples, stinging, or crusting at some point prior to hair loss [<a href="#rid1">1,2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>"What is your normal hair care routine?" </strong>– A history of current or previous traction hairstyles is necessary for a diagnosis of traction alopecia. Knowledge of other hair care practices, such as frequent use of direct heat (eg, flat irons or curling irons) on the hair shaft [<a href="#rid29">29</a>] and chemical relaxers, is useful because such measures increase hair fragility and may contribute to additional hair loss [<a href="#rid30">30,31</a>]. Additionally, patients may use various techniques to maintain their hairstyles while sleeping in order to avoid time-consuming and/or expensive hair care [<a href="#rid32">32</a>]. Increased awareness of "nocturnal traction" and asking patients "How do you wear your hair when you sleep?" may further help identify at-risk patients.</p><p></p><p class="headingAnchor" id="H178861470"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>The physical examination of a patient with suspected traction alopecia on the scalp should include assessment of both the scalp and hair.</p><p>The examination should begin with a global assessment of the general appearance of the hair. The texture, color, and length of the hair as well as the current hairstyle should be noted, as variations of these features can mask or augment the appearance of hair loss. If there is recognizable hair loss, the pattern and severity of hair loss should be assessed. In traction alopecia, the distribution of hair loss should correlate with the areas subjected to traction.</p><p>Examination of the scalp can be performed by examining the skin along the hairline, then parting the hair in a systematic manner that allows for a thorough assessment of the scalp skin. Particular attention should be paid to signs of inflammation (eg, erythema, inflamed papules, pustules, or scale) as these may indicate traction folliculitis, as well as to the presence or absence of follicular ostia in the involved areas. In traction alopecia, follicular ostia are usually retained, with the exception of late-stage disease, which may have diminished follicular ostia.</p><p>Closer examination should include visual assessment of hair fibers in the involved areas. In traction alopecia, hair fibers often become finer as a result of follicular damage or follicular miniaturization. The clinician should also examine the patient for the presence of hair casts. Hair casts frequently occur in traction alopecia and are an indicator of persistent traction [<a href="#rid23">23-26</a>]. Hair pull tests, which are used to assess for hair cycle disturbances resulting in hair loss, are typically negative in traction alopecia. (See  <a class="medical medical_review" href="/z/d/html/15678.html" rel="external">"Evaluation and diagnosis of hair loss", section on 'Hair pull test'</a>.)</p><p>In clinical studies, the severity of marginal traction alopecia has been assessed using the Marginal Traction Alopecia Severity (M-TAS) score [<a href="#rid17">17</a>].</p><p>Dermoscopic examination is a useful adjunctive tool in the diagnosis of traction alopecia. Dermoscopy may detect hair casts that are less easily seen with the naked eye [<a href="#rid23">23</a>]. In addition, dermoscopy may be helpful in visualizing the follicular ostia (pinpoint white dots), which can be diminished in persistent traction alopecia. The presence of empty follicles, vellus hairs, broken hairs, black dots, and circular hairs may also help support the diagnosis of traction alopecia, though these changes may vary depending on whether the traction is early or late stage [<a href="#rid33">33,34</a>]. (See  <a class="medical medical_review" href="/z/d/html/13521.html" rel="external">"Overview of dermoscopy"</a>.)</p><p class="headingAnchor" id="H178861655"><span class="h2">Biopsy</span><span class="headingEndMark"> — </span>A biopsy is not necessary for the diagnosis of traction alopecia in the majority of cases but should be done when there is doubt regarding the diagnosis. In contrast to many other hair loss disorders, the biopsy should be from the center as opposed to the periphery of an alopecic area. (See  <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">"Skin biopsy techniques"</a>.)</p><p>One 4 mm punch biopsy sectioned horizontally may allow for the detection of histologic findings consistent with traction alopecia. However, many dermatopathologists prefer two biopsies to allow for examination of both horizontal and vertical sections. (See <a class="local">'Histopathology'</a> above.)</p><p class="headingAnchor" id="H636697"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of traction alopecia differs based upon whether the patient presents with traction folliculitis, marginal tractional alopecia, or nonmarginal alopecia  (<a class="graphic graphic_table graphicRef102269" href="/z/d/graphic/102269.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H420826437"><span class="h2">Traction folliculitis</span><span class="headingEndMark"> — </span>Pustular eruptions secondary to bacterial folliculitis or tinea capitis are in the differential diagnosis of early traction folliculitis. Bacterial or fungal cultures can differentiate these conditions from the sterile pustules of traction folliculitis. Of note, the lymphadenopathy often present in tinea capitis is absent in traction alopecia. (See  <a class="medical medical_review" href="/z/d/html/103297.html" rel="external">"Infectious folliculitis"</a> and  <a class="medical medical_review" href="/z/d/html/99983.html" rel="external">"Tinea capitis"</a>.)</p><p class="headingAnchor" id="H420826465"><span class="h2">Marginal traction alopecia</span><span class="headingEndMark"> — </span>Marginal traction alopecia may resemble the ophiasis pattern of alopecia areata and frontal fibrosing alopecia:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alopecia areata </strong>– Alopecia areata is an autoimmune condition that usually presents with sudden-onset patchy hair loss. Occasionally, hair loss occurs in a band-like distribution along the hairline, known as the ophiasis pattern  (<a class="graphic graphic_picture graphicRef101627" href="/z/d/graphic/101627.html" rel="external">picture 6</a>). This presentation can be difficult to distinguish clinically from traction alopecia. Both disorders usually exhibit retained follicular ostia. The presence of exclamation point hairs (short hairs less than a few millimeters in length with tapered bases) within the involved area suggests alopecia areata  (<a class="graphic graphic_picture graphicRef65864" href="/z/d/graphic/65864.html" rel="external">picture 7</a>). When necessary, a biopsy can aid in distinguishing these disorders. Histopathologic examination of alopecia areata reveals peribulbar lymphocytic inflammation and an absence of fibrotic fibrous tracts. (See  <a class="medical medical_review" href="/z/d/html/3320.html" rel="external">"Alopecia areata: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Frontal fibrosing alopecia</strong> – Traction alopecia involving the frontal and temporal hairline can be difficult to distinguish from frontal fibrosing alopecia (FFA), an uncommon form of cicatricial (scarring) alopecia  (<a class="graphic graphic_picture graphicRef101628 graphicRef90010" href="/z/d/graphic/101628.html" rel="external">picture 8A-B</a>). Both conditions present with hair loss in a band-like pattern along the frontal hairline. In FFA, there is loss of the follicular ostia, and the involved scalp appears pale and sclerotic. Isolated terminal hairs may remain in areas of involvement (the "lonely hair sign") and there is an absence of vellus hairs [<a href="#rid35">35</a>]. The "fringe sign" of traction alopecia is absent. Eyebrow loss is a common associated feature of FFA. Hyperpigmentation of the face and neck consistent with lichen planus pigmentosus may be another frequent associated finding in patients with highly pigmented skin [<a href="#rid36">36</a>]. Histopathologic examination of FFA shows a loss of sebaceous glands and an inflammatory infiltrate and interface dermatitis around hair follicles. (See  <a class="medical medical_review" href="/z/d/html/15680.html" rel="external">"Lichen planopilaris", section on 'Frontal fibrosing alopecia'</a>.)</p><p></p><p class="headingAnchor" id="H420826524"><span class="h2">Nonmarginal traction alopecia</span><span class="headingEndMark"> — </span>Nonmarginal traction alopecia should be distinguished from hair loss secondary to trichotillomania, syphilis, alopecia areata, or tinea capitis:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trichotillomania</strong> – Trichotillomania is a condition in which a person pulls, twists, plucks, or otherwise manipulates the hair in an obsessive or repetitive manner to the point where there is visible hair loss  (<a class="graphic graphic_picture graphicRef102267" href="/z/d/graphic/102267.html" rel="external">picture 9</a>). Unlike many cases of traction alopecia, the hair loss in trichotillomania usually spares the marginal hairline because manipulation of hair in these areas may be more painful. In the areas of hair loss, the hair shafts are broken, with blunt ends, and there may be signs of irritation or trauma of the scalp. Often, trichotillomania is associated with other behavioral or psychiatric disorders including anxiety, depression, obsessive-compulsive disorders, or others. On histologic examination, pigment casts, trichomalacia (twisted or deformed hairs), and a catagen shift may be present. (See  <a class="medical medical_review" href="/z/d/html/13698.html" rel="external">"Skin picking (excoriation) disorder and related disorders", section on 'Trichotillomania'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Syphilis</strong> – Patchy hair loss often described as a "moth-eaten" pattern can occur in secondary syphilis  (<a class="graphic graphic_picture graphicRef52213" href="/z/d/graphic/52213.html" rel="external">picture 10</a>). This pattern of hair loss may be similar to the patchy traction alopecia that can occur as a result of hair extensions. A high level of suspicion is always warranted, and appropriate serology should be ordered if syphilis is suspected. (See  <a class="medical medical_review" href="/z/d/html/7588.html" rel="external">"Syphilis: Screening and diagnostic testing"</a> and  <a class="medical medical_review" href="/z/d/html/7584.html" rel="external">"Syphilis: Epidemiology, pathophysiology, and clinical manifestations in patients without HIV", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Alopecia areata</strong> – Patchy alopecia areata can resemble nonmarginal traction alopecia. The onset of alopecia areata tends to be sudden, unlike the typical gradual onset of traction alopecia. Alopecia areata is also in the differential diagnosis of marginal traction alopecia. (See <a class="local">'Marginal traction alopecia'</a> above and  <a class="medical medical_review" href="/z/d/html/3320.html" rel="external">"Alopecia areata: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tinea capitis </strong>– Tinea capitis is a common disorder in children that may present with patchy hair loss. Scale is usually present and is typically more prominent than the mild scale that may accompany traction alopecia  (<a class="graphic graphic_picture graphicRef101630" href="/z/d/graphic/101630.html" rel="external">picture 11</a>). A potassium hydroxide (KOH) preparation of involved hairs or fungal culture confirms a diagnosis of tinea capitis. (See  <a class="medical medical_review" href="/z/d/html/99983.html" rel="external">"Tinea capitis"</a>.)</p><p></p><p class="headingAnchor" id="H203854875"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Data on the treatment of traction alopecia are limited. No controlled trials have been performed, and recommendations in the literature are primarily based on case reports and expert opinion.</p><p>The therapeutic options for traction alopecia include behavioral changes and medications aimed at halting progression of the disorder and promoting regrowth of hair. When treatment is unable to induce adequate hair regrowth, as is often the case for late-stage disease, hair transplantation or cosmetic techniques to camouflage hair loss can be beneficial. (See <a class="local">'Early-stage traction alopecia'</a> below and <a class="local">'Late-stage traction alopecia'</a> below and <a class="local">'Cosmetic camouflage'</a> below.)</p><p class="headingAnchor" id="H203854887"><span class="h2">Early-stage traction alopecia</span><span class="headingEndMark"> — </span>The detection of traction alopecia at an early stage (within one year of onset) is desirable because the potential for hair regrowth diminishes with increasing duration of traction and increasing severity of alopecia. The most important intervention for early-stage traction alopecia is discontinuation of the traction hairstyle. Adjunctive interventions, such as topical or intralesional corticosteroids, oral antibiotics, and topical <a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">minoxidil</a> are often used to in an attempt to minimize additional hair loss and augment regrowth of hair. (See <a class="local">'Cessation of traction hairstyles'</a> below and <a class="local">'Adjunctive interventions'</a> below.)</p><p class="headingAnchor" id="H14318532"><span class="h3">Cessation of traction hairstyles</span><span class="headingEndMark"> — </span>Discontinuation of traction hairstyles is recommended for all patients with traction alopecia. In general, this would include avoidance of particular styles of braids, weaves, twists, dreadlocks, ponytails, hair buns, hair extensions, or other styling techniques that exert tension on the hair. Loose, low-hanging ponytails or buns are preferred methods for tying hair because of a lower risk of TA, especially in natural hair [<a href="#rid17">17,37</a>].</p><p>However, changing hairstyling techniques can be difficult for patients because of strong personal preference or cultural, religious, or professional requirements. Patients who are unable to completely discontinue a traction hairstyle should be encouraged to alter the hairstyle in a manner that minimizes tension on the hair. In addition, patients should be educated that the development of pain, tenderness, or pimples from a hairstyle should not be tolerated. If such symptoms occur, the hairstyle should be removed or adjusted immediately. Taking down the traction hairstyle when at home may be an additional helpful measure for patients who are required to wear a traction hairstyle in professional or social settings.</p><p>In addition, we typically encourage patients to avoid insults to the hair that may cause hair breakage, augmenting the extent of hair loss. Avoidance of chemical relaxers and appliances that directly apply heat to the hair shaft (eg, curling irons or flatirons) is preferred, though not always feasible for patients. In particular, because limited data suggest that wearing traction-inducing hairstyles on chemically relaxed hair may increase risk for traction alopecia [<a href="#rid17">17</a>], we encourage patients who are unable to stop traction hairstyles to discontinue use of chemical relaxers.</p><p class="headingAnchor" id="H14318544"><span class="h3">Adjunctive interventions</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">Minoxidil</a> is often used in an attempt to augment the growth of hairs in affected areas. In addition, interventions to reduce active inflammation, such as topical or intralesional corticosteroid therapy and oral antibiotics with antiinflammatory properties are often prescribed in an attempt to reduce the inflammatory response that may contribute to hair loss in traction alopecia. Although these treatments are commonly used [<a href="#rid38">38</a>], they have not been evaluated in clinical trials.</p><p>Our typical initial approach to adjunctive therapy consists of treatment with topical <a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">minoxidil</a> for patients with early-stage traction alopecia who present<strong> without</strong> clinical signs of active inflammation (eg, erythema, inflamed papules, pustules, or scale). When patients present with clinical signs of inflammation, we usually begin with either local administration of a corticosteroid or administration of an oral <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">tetracycline</a> antibiotic. The latter is preferred when pustules are present [<a href="#rid38">38</a>]. Patients are transitioned to topical minoxidil therapy once signs of inflammation subside.</p><p class="headingAnchor" id="H420825991"><span class="h4">Minoxidil</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">Minoxidil</a>, a drug frequently used for androgenetic alopecia, is also used in an attempt to improve hair growth in traction alopecia. It is theorized that minoxidil may prolong the anagen (growth) phase of hair follicles, shorten the telogen (resting) phase, and induce enlargement of miniaturized follicles, thereby contributing to the conversion of miniaturized hairs to terminal hairs [<a href="#rid39">39</a>].</p><p><a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">Minoxidil</a> can be used either topically or orally, with the former being available over the counter and the latter given as a prescription. We generally start with topical minoxidil due to its favorable safety profile. We consider oral minoxidil therapy for patients who have had no significant improvement with topical minoxidil after six to nine months of daily treatment. Data on the efficacy for traction alopecia are limited to case reports and case series [<a href="#rid40">40-42</a>]. (See  <a class="medical medical_review" href="/z/d/html/3321.html" rel="external">"Male pattern hair loss (androgenetic alopecia in males): Management"</a>.)</p><p>Topical <a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">minoxidil</a> is commercially available in a 5% solution or foam and a 2% solution. We typically instruct patients to apply minoxidil 5% solution or foam once daily to the scalp. Twice-daily application of minoxidil 2% solution is an alternative. Oral minoxidil is generally prescribed in doses of 0.625 to 5 mg daily.</p><p>Treatment should be continued for at least four months prior to assessing for initial signs of a response. A full year of treatment may be necessary to judge efficacy. If hair growth improves, treatment should be continued until regrowth is stable for at least three to four months.</p><p>Skin irritation and facial hair growth are potential side effects of topical <a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">minoxidil</a>. The 5% foam formulations may be less likely to cause skin irritation than 2% solutions. However, in women, the risk for facial hypertrichosis may be greater with the 5% formulation than with the 2% formulation [<a href="#rid43">43</a>]. Facial hypertrichosis typically resolves within a few months after cessation of minoxidil [<a href="#rid43">43</a>]. Initial shedding of hair during the first several weeks of treatment may also be seen [<a href="#rid44">44</a>].</p><p>Potential side effects of low-dose oral <a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">minoxidil</a> include hypertrichosis, light headedness, tachycardia, and fluid retention (leg swelling), though the low doses of this antihypertensive drug are generally well tolerated [<a href="#rid41">41,45</a>].</p><p class="headingAnchor" id="H106065860"><span class="h4">Local corticosteroids</span><span class="headingEndMark"> — </span>Patients with clinical signs of inflammation may benefit from local corticosteroid therapy. Local corticosteroids can be administered through application of medium- to high-potency topical corticosteroids (group 2 to 4  (<a class="graphic graphic_table graphicRef62402" href="/z/d/graphic/62402.html" rel="external">table 2</a>)) or through intralesional injection [<a href="#rid6">6,38,46,47</a>].</p><p>Topical corticosteroid therapy is usually applied twice daily to the entire affected area. Intralesional corticosteroid therapy is often administered as a 10 mg/mL concentration of <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">triamcinolone</a> acetonide. Both the center and periphery of the area of hair loss should be injected. Individual injections are typically spaced approximately 1 cm apart with approximately 0.1 mL injected per site. Injection sessions are typically performed at an interval of four to six weeks. We typically do not administer more than 20 mg of triamcinolone acetonide per treatment session. (See  <a class="medical medical_review" href="/z/d/html/5568.html" rel="external">"Intralesional corticosteroid injection"</a>.)</p><p>Treatment with these agents is discontinued once clinical signs of inflammation resolve. A typical course of treatment is one to two months for topical corticosteroids and two injection sessions for intralesional corticosteroids.</p><p>Skin atrophy is a potential adverse effect of local corticosteroid therapy. The side effects of topical and intralesional corticosteroid therapy are reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5565.html" rel="external">"Topical corticosteroids: Use and adverse effects", section on 'Adverse effects'</a> and  <a class="medical medical_review" href="/z/d/html/5568.html" rel="external">"Intralesional corticosteroid injection", section on 'Adverse effects and pitfalls'</a>.)</p><p class="headingAnchor" id="H106065867"><span class="h4">Oral antibiotics</span><span class="headingEndMark"> — </span>Oral <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">tetracycline</a> antibiotics (eg, tetracycline, <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a>, <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">minocycline</a>) are commonly used for traction alopecia in patients with clinical signs of inflammation based upon the antiinflammatory effects of these drugs. Use of these agents is preferred over local corticosteroids when pustules are present [<a href="#rid38">38</a>].</p><p>Typical adult doses are similar to those used for acne and include <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">tetracycline</a> (500 mg twice daily), <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (50 to 100 mg twice daily), or <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">minocycline</a> (50 to 100 mg twice daily). Treatment is continued until clinical signs of inflammation resolve. A typical treatment course is one month or until resolution of the folliculitis.</p><p>Tetracyclines should not be administered to children under the age of nine years or pregnant women because of risk for discoloration of developing permanent teeth. Common side effects of <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">tetracycline</a> and <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> include gastrointestinal distress and photosensitivity. <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">Minocycline</a> use may be associated with gastrointestinal distress, dizziness, skin discoloration, serum sickness, or a lupus-like syndrome.</p><p class="headingAnchor" id="H203854913"><span class="h2">Late-stage traction alopecia</span><span class="headingEndMark"> — </span>Patients presenting with traction alopecia that has persisted for years are unlikely to experience significant hair regrowth with treatment. Still, attempts to maximize any potential for regrowth through removal of the traction-inducing hairstyle (if still in use) and a trial of topical <a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">minoxidil</a> is reasonable [<a href="#rid40">40</a>]. (See <a class="local">'Cessation of traction hairstyles'</a> above and <a class="local">'Minoxidil'</a> above.)</p><p>Patients with permanent hair loss may achieve cosmetic benefits from hair transplantation. Cosmetic camouflage techniques are an alternative to hair transplantation. (See <a class="local">'Hair transplantation'</a> below and <a class="local">'Cosmetic camouflage'</a> below.)</p><p class="headingAnchor" id="H178859993"><span class="h3">Hair transplantation</span><span class="headingEndMark"> — </span>Hair transplantation can restore hair growth in areas of traction alopecia. Hair transplants performed with micro-grafting, mini-grafting, and follicular unit transplantation have been reported as effective in individual patients [<a href="#rid38">38,48,49</a>]. Of note, special consideration should be given to hair shape and styling methods to achieve the best results from hair transplantation in patients with curly, Afro-textured hair [<a href="#rid50">50,51</a>]. For example, care must be taken to avoid transection of curved hair follicles when separating grafts [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H14318258"><span class="h3">Cosmetic camouflage</span><span class="headingEndMark"> — </span>A variety of interventions can effectively conceal areas of hair loss [<a href="#rid52">52</a>]. Cosmetics that decrease the color contrast between the scalp and hair can reduce the visibility of hair loss and are available in a variety of application methods (eg, topical hair fibers, powders, camouflaging lotions or sprays, and scalp tattoos) [<a href="#rid52">52</a>]. Use of a hair piece or wig is also helpful for camouflaging hair loss from traction alopecia, provided tight clips, glues, or tape are not used.</p><p class="headingAnchor" id="H203854919"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The prognosis for traction alopecia is excellent if traction is stopped early in the course of the disorder. However, chronic traction alopecia eventually becomes permanent and unresponsive to cessation of traction and pharmacologic interventions. (See <a class="local">'Management'</a> above.)</p><p class="headingAnchor" id="H637652"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Traction alopecia is preventable. Unfortunately, knowledge about traction alopecia is still poor among teenagers and many communities [<a href="#rid53">53</a>]. Programs to educate adults and parents or guardians of children and adolescents about the risk factors for traction alopecia and early signs of traction alopecia may aid in reducing incidence [<a href="#rid37">37,54</a>]. Educating hairdressers may also be of benefit for the prevention and early detection of traction alopecia.</p><p>Key messages to communicate to the public include:</p><p class="bulletIndent1"><span class="glyph">●</span>Hairstyles should be painless; a painful hairstyle should be removed immediately.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hairstyles causing skin redness, pimples, or hair loss should be removed immediately.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Traction hairstyles (eg, braids or weaves) should be worn infrequently and for short periods.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>It is preferable to avoid traction hairstyles on chemically relaxed hair.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Massaging or vigorously brushing the affected scalp does not stimulate hair regrowth and is not recommended for traction alopecia.</p><p></p><p>Clinicians may also help to reduce the burden of traction alopecia by recognizing signs of traction alopecia in children or adults who present for the evaluation of other medical conditions. A discussion about methods to avoid additional hair loss may stimulate behavioral changes and benefit patients with traction alopecia.</p><p class="headingAnchor" id="H203854925"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Traction alopecia is a type of hair loss that occurs as a result of prolonged or repetitive tension on hair and hair follicles. Traction hairstyles, such as braids, hair weaves, tight ponytails, or tight hair buns can lead to the development of traction alopecia. (See <a class="local">'Epidemiology and risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Traction alopecia is most frequently diagnosed in females of African descent with Afro-textured hair because of the common use of traction hairstyles in this population. However, traction alopecia can occur in children or adults with any type of hair. (See <a class="local">'Epidemiology and risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical features</strong> – The earliest clinical sign of traction alopecia may be the development of traction folliculitis. Traction folliculitis is characterized by the development of perifollicular erythema, inflamed papules, or pustules in sites of traction on hair  (<a class="graphic graphic_picture graphicRef101620" href="/z/d/graphic/101620.html" rel="external">picture 2</a>). (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1">The location of hair loss in traction alopecia correlates with the site(s) of traction. Hair loss most frequently occurs on the frontal or temporal scalp  (<a class="graphic graphic_picture graphicRef101621" href="/z/d/graphic/101621.html" rel="external">picture 1A</a>). The "fringe sign," persistence of fine or miniaturized hairs in the anterior hairline with greater hair loss posterior to this fringe, is a common finding  (<a class="graphic graphic_picture graphicRef101622" href="/z/d/graphic/101622.html" rel="external">picture 1B</a>). (See <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of traction alopecia usually can be made based upon the clinical evaluation. A history of a traction hairstyle and hair loss in a correlating distribution is essential for diagnosis. A biopsy can be helpful if the diagnosis is uncertain. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Early recognition of traction alopecia is critical. Patients with early traction alopecia may experience significant hair regrowth with treatment. Hair regrowth is less likely to occur in longstanding traction alopecia (see <a class="local">'Prognosis'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cessation of traction</strong> – Discontinuation of traction hairstyles is the primary treatment for traction alopecia. Modifications of hairstyling routines may be necessary for patients who cannot completely discontinue traction hairstyles for professional, cultural, religious, or other reasons. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Adjunctive therapies</strong> – Adjunctive therapies are often prescribed in an attempt to minimize additional hair loss and augment hair regrowth. We suggest a trial of topical <a class="drug drug_general" data-topicid="9655" href="/z/d/drug information/9655.html" rel="external">minoxidil</a> for patients who desire treatment (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). If signs of inflammation are present, treatment with local corticosteroids or oral antiinflammatory antibiotics is typically given prior to minoxidil treatment. Oral minoxidil is an option for patients who respond insufficiently to topical minoxidil treatment. (See <a class="local">'Adjunctive interventions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – Traction alopecia is preventable. Education of the public may help to reduce the incidence of traction alopecia. (See <a class="local">'Prevention'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Hairdressing and the prevalence of scalp disease in African adults. Br J Dermatol 2007; 157:981.</a></li><li><a class="nounderline abstract_t">Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Hairdressing is associated with scalp disease in African schoolchildren. Br J Dermatol 2007; 157:106.</a></li><li><a class="nounderline abstract_t">Rucker Wright D, Gathers R, Kapke A, et al. Hair care practices and their association with scalp and hair disorders in African American girls. J Am Acad Dermatol 2011; 64:253.</a></li><li><a class="nounderline abstract_t">Khumalo NP, Jessop S, Ehrlich R. Prevalence of cutaneous adverse effects of hairdressing: a systematic review. Arch Dermatol 2006; 142:377.</a></li><li><a class="nounderline abstract_t">HJORTH N. Traumatic marginal alopecia; a special type: alopecia groenlandica. Br J Dermatol 1957; 69:319.</a></li><li><a class="nounderline abstract_t">Samrao A, Price VH, Zedek D, Mirmirani P. The "Fringe Sign" - A useful clinical finding in traction alopecia of the marginal hair line. Dermatol Online J 2011; 17:1.</a></li><li><a class="nounderline abstract_t">Goren A, Wei L, Tan Y, et al. Frontal pattern hair loss among Chinese women is frequently associated with ponytail hairstyle. Dermatol Ther 2019; 32:e12784.</a></li><li><a class="nounderline abstract_t">Samrao A, Chen C, Zedek D, Price VH. Traction alopecia in a ballerina: clinicopathologic features. Arch Dermatol 2010; 146:930.</a></li><li><a class="nounderline abstract_t">Trüeb RM. "Chignon alopecia": a distinctive type of nonmarginal traction alopecia. Cutis 1995; 55:178.</a></li><li><a class="nounderline abstract_t">Yang A, Iorizzo M, Vincenzi C, Tosti A. Hair extensions: a concerning cause of hair disorders. Br J Dermatol 2009; 160:207.</a></li><li><a class="nounderline abstract_t">Renna FS, Freedberg IM. Traction alopecia in nurses. Arch Dermatol 1973; 108:694.</a></li><li><a class="nounderline abstract_t">Kanwar AJ, Kaur S, Basak P, Sharma R. Traction alopecia in Sikh males. Arch Dermatol 1989; 125:1587.</a></li><li><a class="nounderline abstract_t">James J, Saladi RN, Fox JL. Traction alopecia in Sikh male patients. J Am Board Fam Med 2007; 20:497.</a></li><li><a class="nounderline abstract_t">Korona-Bailey J, Banaag A, Nguyen DR, et al. Free the Bun: Prevalence of Alopecia Among Active Duty Service Women, Fiscal Years 2010-2019. Mil Med 2023; 188:e492.</a></li><li><a class="nounderline abstract_t">May Franklin JM, Wohltmann WE, Wong EB. From Buns to Braids and Ponytails: Entering a New Era of Female Military Hair-Grooming Standards. Cutis 2021; 108:31.</a></li><li><a class="nounderline abstract_t">Fox GN, Stausmire JM, Mehregan DR. Traction folliculitis: an underreported entity. Cutis 2007; 79:26.</a></li><li><a class="nounderline abstract_t">Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Determinants of marginal traction alopecia in African girls and women. J Am Acad Dermatol 2008; 59:432.</a></li><li><a class="nounderline abstract_t">Miteva M, Tosti A. 'A detective look' at hair biopsies from African-American patients. Br J Dermatol 2012; 166:1289.</a></li><li><a class="nounderline abstract_t">Sperling LC, Lupton GP. Histopathology of non-scarring alopecia. J Cutan Pathol 1995; 22:97.</a></li><li><a class="nounderline abstract_t">Beach RA, Wilkinson KA, Gumedze F, Khumalo NP. Baseline sebum IL-1α is higher than expected in afro-textured hair: a risk factor for hair loss? J Cosmet Dermatol 2012; 11:9.</a></li><li><a class="nounderline abstract_t">Heath CR, Taylor SC. Alopecia in an ophiasis pattern: traction alopecia versus alopecia areata. Cutis 2012; 89:213.</a></li><li><a class="nounderline abstract_t">Ahdout J, Mirmirani P. Weft hair extensions causing a distinctive horseshoe pattern of traction alopecia. J Am Acad Dermatol 2012; 67:e294.</a></li><li><a class="nounderline abstract_t">Tosti A, Miteva M, Torres F, et al. Hair casts are a dermoscopic clue for the diagnosis of traction alopecia. Br J Dermatol 2010; 163:1353.</a></li><li><a class="nounderline abstract_t">ROLLINS TG. Traction follicultis with hair casts and alopecia. Am J Dis Child 1961; 101:639.</a></li><li><a class="nounderline abstract_t">Ozuguz P, Kacar S, Takci Z, et al. Generalized hair casts due to traction. Pediatr Dermatol 2013; 30:614.</a></li><li><a class="nounderline abstract_t">Zhang W. Epidemiological and aetiological studies on hair casts. Clin Exp Dermatol 1995; 20:202.</a></li><li><a class="nounderline abstract_t">Goldberg LJ. Cicatricial marginal alopecia: is it all traction? Br J Dermatol 2009; 160:62.</a></li><li><a class="nounderline abstract_t">Ngwanya RM, Adeola HA, Beach RA, et al. Reliability of Histopathology for the Early Recognition of Fibrosis in Traction Alopecia: Correlation with Clinical Severity. Dermatopathology (Basel) 2019; 6:170.</a></li><li><a class="nounderline abstract_t">Mirmirani P. Ceramic flat irons: improper use leading to acquired trichorrhexis nodosa. J Am Acad Dermatol 2010; 62:145.</a></li><li><a class="nounderline abstract_t">Khumalo NP, Stone J, Gumedze F, et al. 'Relaxers' damage hair: evidence from amino acid analysis. J Am Acad Dermatol 2010; 62:402.</a></li><li><a class="nounderline abstract_t">Mkentane K, Maneli M, Khumalo NP, et al. Relaxers damage hair and increase fragility. Int J Dermatol 2014; 53:e200.</a></li><li><a class="nounderline abstract_t">Samrao A, McMichael A, Mirmirani P. Nocturnal Traction: Techniques Used for Hair Style Maintenance while Sleeping May Be a Risk Factor for Traction Alopecia. Skin Appendage Disord 2021; 7:220.</a></li><li><a class="nounderline abstract_t">Shim WH, Jwa SW, Song M, et al. Dermoscopic approach to a small round to oval hairless patch on the scalp. Ann Dermatol 2014; 26:214.</a></li><li><a class="nounderline abstract_t">Polat M. Evaluation of clinical signs and early and late trichoscopy findings in traction alopecia patients with Fitzpatrick skin type II and III: a single-center, clinical study. Int J Dermatol 2017; 56:850.</a></li><li><a class="nounderline abstract_t">Tosti A, Miteva M, Torres F. Lonely hair: a clue to the diagnosis of frontal fibrosing alopecia. Arch Dermatol 2011; 147:1240.</a></li><li><a class="nounderline abstract_t">Dlova NC. Frontal fibrosing alopecia and lichen planus pigmentosus: is there a link? Br J Dermatol 2013; 168:439.</a></li><li><a class="nounderline abstract_t">Haskin A, Aguh C. All hairstyles are not created equal: What the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA). J Am Acad Dermatol 2016; 75:606.</a></li><li><a class="nounderline abstract_t">Callender VD, McMichael AJ, Cohen GF. Medical and surgical therapies for alopecias in black women. Dermatol Ther 2004; 17:164.</a></li><li><a class="nounderline abstract_t">Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol 2004; 150:186.</a></li><li><a class="nounderline abstract_t">Khumalo NP, Ngwanya RM. Traction alopecia: 2% topical minoxidil shows promise. Report of two cases. J Eur Acad Dermatol Venereol 2007; 21:433.</a></li><li><a class="nounderline abstract_t">Beach RA. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability &amp; the five C's of oral therapy. Dermatol Ther 2018; 31:e12707.</a></li><li><a class="nounderline abstract_t">Kim SR, Craiglow BG. Treatment of traction alopecia with oral minoxidil. JAAD Case Rep 2022; 23:112.</a></li><li><a class="nounderline abstract_t">Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 2005; 52:301.</a></li><li><a class="nounderline abstract_t">Blumeyer A, Tosti A, Messenger A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges 2011; 9 Suppl 6:S1.</a></li><li><a class="nounderline abstract_t">Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol 2021; 84:1644.</a></li><li><a class="nounderline abstract_t">Fu JM, Price VH. Approach to hair loss in women of color. Semin Cutan Med Surg 2009; 28:109.</a></li><li><a class="nounderline abstract_t">Uwakwe LN, De Souza B, Tovar-Garza A, McMichael AJ. Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia. J Drugs Dermatol 2020; 19:128.</a></li><li><a class="nounderline abstract_t">Ozçelik D. Extensive traction alopecia attributable to ponytail hairstyle and its treatment with hair transplantation. Aesthetic Plast Surg 2005; 29:325.</a></li><li><a class="nounderline abstract_t">Earles RM. Surgical correction of traumatic alopecia marginalis or traction alopecia in black women. J Dermatol Surg Oncol 1986; 12:78.</a></li><li><a class="nounderline abstract_t">Rogers NE, Callender VD. Advances and challenges in hair restoration of curly Afrocentric hair. Dermatol Clin 2014; 32:163.</a></li><li><a class="nounderline abstract_t">Singh MK, Avram MR. Technical considerations for follicular unit extraction in African-American hair. Dermatol Surg 2013; 39:1282.</a></li><li><a class="nounderline abstract_t">Donovan JC, Shapiro RL, Shapiro P, et al. A review of scalp camouflaging agents and prostheses for individuals with hair loss. Dermatol Online J 2012; 18:1.</a></li><li><a class="nounderline abstract_t">Okoro OE, Imam A, Barminas R. Knowledge of Traction Alopecia and Hair Care Practices among Adolescents in Keffi, North-Central Nigeria. Skin Appendage Disord 2022; 8:129.</a></li><li><a class="nounderline abstract_t">Mirmirani P, Khumalo NP. Traction alopecia: how to translate study data for public education--closing the KAP gap? Dermatol Clin 2014; 32:153.</a></li></ol></div><div id="topicVersionRevision">Topic 99226 Version 8.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17725667" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hairdressing and the prevalence of scalp disease in African adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17553035" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Hairdressing is associated with scalp disease in African schoolchildren.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20728245" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hair care practices and their association with scalp and hair disorders in African American girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16549718" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of cutaneous adverse effects of hairdressing: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13460178" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Traumatic marginal alopecia; a special type: alopecia groenlandica.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22136857" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The "Fringe Sign" - A useful clinical finding in traction alopecia of the marginal hair line.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30458063" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Frontal pattern hair loss among Chinese women is frequently associated with ponytail hairstyle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20713841" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Traction alopecia in a ballerina: clinicopathologic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7634850" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : "Chignon alopecia": a distinctive type of nonmarginal traction alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19014394" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hair extensions: a concerning cause of hair disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4750208" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Traction alopecia in nurses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2817924" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Traction alopecia in Sikh males.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17823469" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Traction alopecia in Sikh male patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34244770" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Free the Bun: Prevalence of Alopecia Among Active Duty Service Women, Fiscal Years 2010-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34397355" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : From Buns to Braids and Ponytails: Entering a New Era of Female Military Hair-Grooming Standards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17330618" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Traction folliculitis: an underreported entity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18694677" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Determinants of marginal traction alopecia in African girls and women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22348354" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : 'A detective look' at hair biopsies from African-American patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7560359" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Histopathology of non-scarring alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22360329" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Baseline sebum IL-1αis higher than expected in afro-textured hair: a risk factor for hair loss?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22768432" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Alopecia in an ophiasis pattern: traction alopecia versus alopecia areata.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23158648" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Weft hair extensions causing a distinctive horseshoe pattern of traction alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20716211" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Hair casts are a dermoscopic clue for the diagnosis of traction alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13742951" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Traction follicultis with hair casts and alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23909653" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Generalized hair casts due to traction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7671413" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Epidemiological and aetiological studies on hair casts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18811691" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Cicatricial marginal alopecia: is it all traction?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31700859" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Reliability of Histopathology for the Early Recognition of Fibrosis in Traction Alopecia: Correlation with Clinical Severity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20082891" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Ceramic flat irons: improper use leading to acquired trichorrhexis nodosa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20159306" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : 'Relaxers' damage hair: evidence from amino acid analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24571594" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Relaxers damage hair and increase fragility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34055912" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Nocturnal Traction: Techniques Used for Hair Style Maintenance while Sleeping May Be a Risk Factor for Traction Alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24882977" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Dermoscopic approach to a small round to oval hairless patch on the scalp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28369851" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Evaluation of clinical signs and early and late trichoscopy findings in traction alopecia patients with Fitzpatrick skin type II and III: a single-center, clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22006155" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Lonely hair: a clue to the diagnosis of frontal fibrosing alopecia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22803712" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Frontal fibrosing alopecia and lichen planus pigmentosus: is there a link?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27114262" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : All hairstyles are not created equal: What the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15113284" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Medical and surgical therapies for alopecias in black women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14996087" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Minoxidil: mechanisms of action on hair growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17309495" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Traction alopecia: 2% topical minoxidil shows promise. Report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30246901" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability&amp;the five C's of oral therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35495975" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Treatment of traction alopecia with oral minoxidil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15692478" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Evaluation and treatment of male and female pattern hair loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21980982" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33639244" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19608062" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Approach to hair loss in women of color.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32129955" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16044234" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Extensive traction alopecia attributable to ponytail hairstyle and its treatment with hair transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3941194" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Surgical correction of traumatic alopecia marginalis or traction alopecia in black women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24680003" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Advances and challenges in hair restoration of curly Afrocentric hair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23668835" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Technical considerations for follicular unit extraction in African-American hair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22948051" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : A review of scalp camouflaging agents and prostheses for individuals with hair loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35419423" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Knowledge of Traction Alopecia and Hair Care Practices among Adolescents in Keffi, North-Central Nigeria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24680002" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Traction alopecia: how to translate study data for public education--closing the KAP gap?</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
